FTY720 has been clinically used in patients with multiple sclerosis; thus, our data suggest that it may also be used to treat patients with increased inflammation associated with high ORMDL3 expression in terms of risk alleles for diseases such as asthma and AR. Here, ORMDL3 is linked to multiple sclerosis.